Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Due to a software error the background illumination of the cupola may not be switched on at the start of an examination. results will appear to be "better" than the actual ones. due to the software error an examination taken with the dynamic or normal strategy may show a huge overshoot in the cumulated defect (bebie) curve and the corresponding visual field indices (md and ms). the effect is less obvious with the top strategy. if these results are considered in isolation from the results of previous visual field examinations or from other examinations (e.G. intraocular pressure measurements or examinations of the optic nerve head) the visual field of the patient may remain untreated.